23
Sep
2026
Long-Lasting Antibodies for Immune Diseases: Cameron Turtle on The Long Run
Cameron Turtle is today’s guest on The Long Run. Cameron is the CEO of Waltham, Mass.-based Spyre Therapeutics. The company is developing antibody drug candidates that are engineered to be longer-lasting than today’s drugs for immune disorders. This means patients could take fewer injections and the drugs should stay stable in the bloodstream to keep the disease under control longer.... Read More